Description
Mazdutide is a synthetic peptide research compound characterized as a dual agonist at the glucagon-like peptide-1 (GLP-1) receptor and the glucagon receptor. It has been studied in preclinical research as a tool compound for isolating incretin and glucagon signaling endpoints in metabolic experimental designs.
Mazdutide has been examined in preclinical in vitro and rodent model studies of glucose homeostasis, appetite-related behavioral paradigms, energy expenditure, and dual receptor signaling dynamics. Its combined receptor activity supports comparative mechanistic studies of incretin and glucagon biology in cell-based and rodent research.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.